Alitame is a dipeptide sweetener containing aspartic acid. It was developed by Pfizer in the early 1980s and is currently marketed in several countries under the brand name Aclame . Most dipeptides are not sweet, but the unexpected discovery of aspartame in 1965 led to the search for similar compounds that share their sweetness. Alitame is one of the second generation dipeptide sweeteners. Neotame, developed by the NutraSweet brand owner, is another.
Alitame is about 2000 times sweeter than sucrose (table sugar), about 10 times sweeter than aspartame, and has no sense of aftertaste. Its beak under hot or acidic conditions is about two times longer than aspartame, although some other artificial sweeteners, including saccharin and potassium acesulfame, are more stable. Unlike aspartame, alitame does not contain phenylalanine, and can therefore be used by people with phenylketonuria.
Alitame has been approved for use in Mexico, Australia, New Zealand and China. Danisco has withdrawn the petition to use alitame as a sweetener or flavoring agent in the United States.
Video Alitame
References
Source of the article : Wikipedia